secwatch.observer — SEC 8-K summary
======================================

Issuer:     CYTOKINETICS INC (CYTK)
CIK:        0001061983
Form:       8-K
Filed at:   2023-10-03T23:59:59+00:00
Accession:  0001193125-23-249298
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cytokinetics adopts executive severance plan with enhanced change-in-control benefits
--------------------------------------------------------------------------------

- Plan covers employees in grades M through P (excluding CEO Blum); severance based on years of service.
- Non-CIC termination: cash lump sum = pro-rated base salary (6–12 months), earned & pro-rated bonus, COBRA.
- CIC termination (within 18 months): severance period 12–18 months, 100% target bonus plus pro-rated bonus.
- Equity awards fully accelerate for CIC terminations, with performance vesting at higher of target or actual.
- Benefits subject to release of claims and compliance with confidentiality and restrictive covenants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1061983/000119312523249298/0001193125-23-249298-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1061983/000119312523249298/d561384d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-249298

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer